Form 4: Entera Bio Director Gerald Ostrov Reports Share Acquisition and Disposal
SEC Form 4
Director Gerald Ostrov reports acquiring 20,446 Entera Bio shares and disposing of 30,446 shares in a recent transaction.
Summary
- On August 27, 2024, Gerald M. Ostrov, a director of Entera Bio Ltd., reported a transaction involving the company's ordinary shares.
- Ostrov acquired 20,446 ordinary shares at a price of $0.
- Simultaneously, Ostrov disposed of 30,446 ordinary shares.
- Following these transactions, Ostrov beneficially owns 30,446 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the trading activities of a company director.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of share acquisition and disposal transaction. |
| 08/29/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.